Aditya Vishwas Karhade

Aditya Vishwas Karhade

Auto-generated profile, based on publicly available information

Aditya Vishwas Karhade

Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in The Spine Journal
Verified
Journal Article
Closed access
AKAditya V. Karhade
Aditya V. Karhade
POPaul T. Ogink
Paul T. Ogink
QTQuirina C.B.S. Thio
Quirina C.B.S. Thio
MBMarike L.D. Broekman
Marike L.D. Broekman
TCThomas D. Cha
Thomas D. Cha
JSJoseph H. Schwab
Joseph H. Schwab

17 December 2021 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
JOJacobien H.F. Oosterhoff
Jacobien H.F. Oosterhoff
BGBenjamin Y. Gravesteijn
Benjamin Y. Gravesteijn
AKAditya V. Karhade
Aditya V. Karhade
RJRuurd L. Jaarsma
Ruurd L. Jaarsma
GKGino M.M.J. Kerkhoffs
Gino M.M.J. Kerkhoffs
TCthe Machine Learning Consortium
the Machine Learning Consortium
Background: Statistical models using machine learning (ML) have the potential for more accurate estimates of the probability of binary events than logistic regression. The present study used existing data sets from large musculoskeletal trauma trials to address the following study questions: (1) Do ML models produce better probability estimates than logistic regression models? (2) Are ML models influenced by different variables than logistic regression models? Methods: We created ML and logistic regression models that estimated the probability of a specific fracture (posterior malleolar involvement in distal spiral tibial shaft and ankle fractures, scaphoid fracture, and distal radial fracture) or adverse event (subsequent surgery [after distal biceps repair or tibial shaft fracture], surgical site infection, and postoperative delirium) using 9 data sets from published musculoskeletal trauma studies. Each data set was split into training (80%) and test (20%) subsets. Fivefold cross-validation of the training set was used to develop the ML models. The best-performing model was then assessed in the independent testing data. Performance was assessed by (1) discrimination (c-statistic), (2) calibration (slope and intercept), and (3) overall performance (Brier score). Results: The mean c-statistic was 0.01 higher for the logistic regression models compared with the best ML models for each data set (range, −0.01 to 0.06). There were fewer variables strongly associated with variation in the ML models, and many were dissimilar from those in the logistic regression models. Conclusions: The observation that ML models produce probability estimates comparable with logistic regression models for binary events in musculoskeletal trauma suggests that their benefit may be limited in this context.

10 May 2022 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Closed access
AKAditya V. Md Karhade
Aditya V. Md Karhade
DBDavid N. Md Bernstein
David N. Md Bernstein
VDVineet Bs Desai
Vineet Bs Desai
HBHany S. Bedair
Hany S. Bedair
EOEvan A. O’donnell
Evan A. O’donnell
DTDaniel G. Tobert
Daniel G. Tobert
Background: Patient-reported outcome measures (PROMs), including the Patient-reported Outcomes Measurement Information System (PROMIS), are increasingly used to measure healthcare value. The minimum clinically important difference (MCID) is a metric that helps clinicians determine whether a statistically detectable improvement in a PROM after surgical care is likely to be large enough to be important to a patient or to justify an intervention that carries risk and cost. There are two major categories of MCID calculation methods, anchor-based and distribution-based. This variability, coupled with heterogeneous surgical cohorts used for existing MCID values, limits their application to clinical care. Questions/purposes: In our study, we sought (1) to determine MCID thresholds and attainment percentages for PROMIS after common orthopaedic procedures using distribution-based methods, (2) to use anchor-based MCID values from published studies as a comparison, and (3) to compare MCID attainment percentages using PROMIS scores to other validated outcomes tools such as the Hip Disability and Osteoarthritis Outcome Score (HOOS) and Knee Disability and Osteoarthritis Outcome Score (KOOS). Methods: This was a retrospective study at two academic medical centers and three community hospitals. The inclusion criteria for this study were patients who were age 18 years or older and who underwent elective THA for osteoarthritis, TKA for osteoarthritis, one-level posterior lumbar fusion for lumbar spinal stenosis or spondylolisthesis, anatomic total shoulder arthroplasty or reverse total shoulder arthroplasty for glenohumeral arthritis or rotator cuff arthropathy, arthroscopic anterior cruciate ligament reconstruction, arthroscopic partial meniscectomy, or arthroscopic rotator cuff repair. This yielded 14,003 patients. Patients undergoing revision operations or surgery for nondegenerative pathologies and patients without preoperative PROMs assessments were excluded, leaving 9925 patients who completed preoperative PROMIS assessments and 9478 who completed other preoperative validated outcomes tools (HOOS, KOOS, numerical rating scale for leg pain, numerical rating scale for back pain, and QuickDASH). Approximately 66% (6529 of 9925) of patients had postoperative PROMIS scores (Physical Function, Mental Health, Pain Intensity, Pain Interference, and Upper Extremity) and were included for analysis. PROMIS scores are population normalized with a mean score of 50 ± 10, with most scores falling between 30 to 70. Approximately 74% (7007 of 9478) of patients had postoperative historical assessment scores and were included for analysis. The proportion who reached the MCID was calculated for each procedure cohort at 6 months of follow-up using distribution-based MCID methods, which included a fraction of the SD (1/2 or 1/3 SD) and minimum detectable change (MDC) using statistical significance (such as the MDC 90 from p < 0.1). Previously published anchor-based MCID thresholds from similar procedure cohorts and analogous PROMs were used to calculate the proportion reaching MCID. Results: Within a given distribution-based method, MCID thresholds for PROMIS assessments were similar across multiple procedures. The MCID threshold ranged between 3.4 and 4.5 points across all procedures using the 1/2 SD method. Except for meniscectomy (3.5 points), the anchor-based PROMIS MCID thresholds (range 4.5 to 8.1 points) were higher than the SD distribution-based MCID values (2.3 to 4.5 points). The difference in MCID thresholds based on the calculation method led to a similar trend in MCID attainment. Using THA as an example, MCID attainment using PROMIS was achieved by 76% of patients using an anchor-based threshold of 7.9 points. However, 82% of THA patients attained MCID using the MDC 95 method (6.1 points), and 88% reached MCID using the 1/2 SD method (3.9 points). Using the HOOS metric (scaled from 0 to 100), 86% of THA patients reached the anchor-based MCID threshold (17.5 points). However, 91% of THA patients attained the MCID using the MDC 90 method (12.5 points), and 93% reached MCID using the 1/2 SD method (8.4 points). In general, the proportion of patients reaching MCID was lower for PROMIS than for other validated outcomes tools; for example, with the 1/2 SD method, 72% of patients who underwent arthroscopic partial meniscectomy reached the MCID on PROMIS Physical Function compared with 86% on KOOS. Conclusion: MCID calculations can provide clinical correlation for PROM scores interpretation. The PROMIS form is increasingly used because of its generalizability across diagnoses. However, we found lower proportions of MCID attainment using PROMIS scores compared with historical PROMs. By using historical proportions of attainment on common orthopaedic procedures and a spectrum of MCID calculation techniques, the PROMIS MCID benchmarks are realizable for common orthopaedic procedures. For clinical practices that routinely collect PROMIS scores in the clinical setting, these results can be used by individual surgeons to evaluate personal practice trends and by healthcare systems to quantify whether clinical care initiatives result in meaningful differences. Furthermore, these MCID thresholds can be used by researchers conducting retrospective outcomes research with PROMIS. Level of Evidence: Level III, therapeutic study.


18 November 2016 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
AKAditya V. Karhade
Aditya V. Karhade
LFLuis Fandino
Luis Fandino
SGSaksham Gupta
Saksham Gupta
DCDavid J. Cote
David J. Cote
JIJ. Bryan Iorgulescu
J. Bryan Iorgulescu
TSTimothy R. Smith
Timothy R. Smith

1 March 2021 in The Spine Journal
Verified
Journal Article
Closed access
AKAditya V. Karhade
Aditya V. Karhade
HFHarold A. Fogel
Harold A. Fogel
TCThomas D. Cha
Thomas D. Cha
SHStuart H. Hershman
Stuart H. Hershman
TDTerence P. Doorly
Terence P. Doorly
DTDaniel G. Tobert
Daniel G. Tobert